{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:17:49Z","timestamp":1778314669010,"version":"3.51.4"},"reference-count":19,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cutaneous and Ocular Toxicology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1080\/15569527.2024.2424932","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T09:00:21Z","timestamp":1731402021000},"page":"405-409","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The treatment efficacy of 7.5% dapsone gel in papulopustular rosacea: a prospective study"],"prefix":"10.1080","volume":"43","author":[{"given":"Defne","family":"\u00d6zkoca","sequence":"first","affiliation":[{"name":"Dermatology and Venerology Clinic, Zonguldak Atat\u00fcrk State Hospital, Zonguldak, Turkey"},{"name":"Department of Dermatology and Venerology, Ko\u00e7 University Medical Faculty, \u0130stanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazl\u0131","family":"Caf","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology Department, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, \u0130stanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.077"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14349"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2016.10.010"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728210903251690"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16074"},{"issue":"6","key":"e_1_3_5_7_1","first-page":"602","article-title":"Dapsone gel in the treatment of papulopustular rosacea: a double-blind randomized clinical trial","volume":"14","author":"Faghihi G","year":"2015","unstructured":"Faghihi G, Khosravani P, Nilforoushzadeh MA, et\u00a0al. Dapsone gel in the treatment of papulopustular rosacea: a double-blind randomized clinical trial. J Drugs Dermatol. 2015;14(6):602\u2013606. PMID: 26091386.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18721"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.037"},{"issue":"4","key":"e_1_3_5_10_1","first-page":"43","article-title":"Once-daily dapsone 7.5% gel for the treatment of acne vulgaris in preadolescent patients: a phase IV, open-label, 12-week study","volume":"14","author":"Moore AY","year":"2021","unstructured":"Moore AY, Lain EL, McMichael A, et\u00a0al. Once-daily dapsone 7.5% gel for the treatment of acne vulgaris in preadolescent patients: a phase IV, open-label, 12-week study. J Clin Aesthet Dermatol. 2021;14(4):43\u201348. Epub 2021 Apr 1. PMID: 34055189; PMCID: PMC8142824.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"8","key":"e_1_3_5_11_1","first-page":"45","article-title":"Management of truncal acne vulgaris with topical dapsone 7.5% gel","volume":"11","author":"Del Rosso JQ","year":"2018","unstructured":"Del Rosso JQ, Kircik L, Tanghetti E. Management of truncal acne vulgaris with topical dapsone 7.5% gel. J Clin Aesthet Dermatol. 2018;11(8):45\u201350. Epub 2018 Aug 1. PMID: 30214667; PMCID: PMC6122512.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"e_1_3_5_12_1","first-page":"602","article-title":"Clinical experience with once-daily dapsone gel, 7.5% monotherapy in patients with acne vulgaris","volume":"17","author":"Stockton TC","year":"2018","unstructured":"Stockton TC, Tanghetti EA, Lain E, et\u00a0al. Clinical experience with once-daily dapsone gel, 7.5% monotherapy in patients with acne vulgaris. J Drugs Dermatol. 2018;17(6):602\u2013608. PMID: 29879247.","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"e_1_3_5_13_1","first-page":"1192","article-title":"Once-daily topical dapsone gel, 7.5%: effective for acne vulgaris regardless of baseline lesion count, with superior efficacy in females","volume":"17","author":"Tanghetti E","year":"2018","unstructured":"Tanghetti E, Harper J, Baldwin H, et\u00a0al. Once-daily topical dapsone gel, 7.5%: effective for acne vulgaris regardless of baseline lesion count, with superior efficacy in females. J Drugs Dermatol. 2018;17(11):1192\u20131198. PMID: 30500141.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"e_1_3_5_14_1","first-page":"160","article-title":"Efficacy, safety, and tolerability of topical dapsone gel, 7.5% for treatment of acne vulgaris by fitzpatrick skin phototype","volume":"17","author":"Taylor SC","year":"2018","unstructured":"Taylor SC, Cook-Bolden FE, McMichael A, et\u00a0al. Efficacy, safety, and tolerability of topical dapsone gel, 7.5% for treatment of acne vulgaris by fitzpatrick skin phototype. J Drugs Dermatol. 2018;17(2):160\u2013167. PMID: 29462223.","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"e_1_3_5_15_1","first-page":"1250","article-title":"Safety and pharmacokinetics of once-daily dapsone gel, 7.5% in patients with moderate acne vulgaris","volume":"15","author":"Jarratt MT","year":"2016","unstructured":"Jarratt MT, Jones TM, Chang-Lin JE, et\u00a0al. Safety and pharmacokinetics of once-daily dapsone gel, 7.5% in patients with moderate acne vulgaris. J Drugs Dermatol. 2016;15(10):1250\u20131259. PMID: 27741344.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"e_1_3_5_16_1","first-page":"591","article-title":"Treatment response with once-daily topical dapsone gel, 7.5% for acne vulgaris: Subgroup analysis of pooled data from two randomized, double-blind stu","volume":"16","author":"Draelos ZD","year":"2017","unstructured":"Draelos ZD, Rodriguez DA, Kempers SE, et\u00a0al. Treatment response with once-daily topical dapsone gel, 7.5% for acne vulgaris: Subgroup analysis of pooled data from two randomized, double-blind stu. J Drugs Dermatol. 2017;16(6):591\u2013598. PMID: 28686777.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"e_1_3_5_17_1","first-page":"553","article-title":"Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: first of two identically designed, large, multicenter, randomized, vehicle-controlled trials","volume":"15","author":"Stein Gold LF","year":"2016","unstructured":"Stein Gold LF, Jarratt MT, Bucko AD, et\u00a0al. Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: first of two identically designed, large, multicenter, randomized, vehicle-controlled trials. J Drugs Dermatol. 2016;15(5):553\u2013561. PMID: 27168264.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1401a34"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14374"},{"issue":"2","key":"e_1_3_5_20_1","first-page":"416","article-title":"Dapsone in dermatology","volume":"8","author":"Caf N","year":"2022","unstructured":"Caf N, \u00d6zkoca D, Kutlubay Z. Dapsone in dermatology. Dermatol Clin Res. 2022;8(2):416\u2013422.","journal-title":"Dermatol Clin Res"}],"container-title":["Cutaneous and Ocular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15569527.2024.2424932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:59:00Z","timestamp":1733158740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15569527.2024.2424932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1080\/15569527.2024.2424932"],"URL":"https:\/\/doi.org\/10.1080\/15569527.2024.2424932","relation":{},"ISSN":["1556-9527","1556-9535"],"issn-type":[{"value":"1556-9527","type":"print"},{"value":"1556-9535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icot20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icot20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}